Concepedia

Publication | Closed Access

Response assessment using [<sup>68</sup>Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer

DOI

68

Citations

18

References

2019

Year

Bernhard Grubmüller, Sazan Rasul, Pascal Baltzer, Harun Fajković, David D‘Andrea, Florian Berndl, Agnes Maj‐Hes, Karl Hermann Grubmüller, Markus Mitterhauser, Wolfgang Wadsak,
The Prostate

Abstract

PSMA-PET provides reliable parameters for prediction of response to systemic therapies for mCRPC. These parameters, if confirmed, could enhance RECIST criteria, specifically concerning its limitations for sclerotic bone lesions.

References

YearCitations

Page 1